Related Experiment Video
Updated: May 23, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Mitigating algorithmic bias in AI-powered toxicology: Frameworks for explainable and equitable predictions in human
Olawale M Ajisafe1, Lydia Adeola Ogebule1, Eghosasere Egbon2
1Department of Comparative Biomedical Science, College of Veterinary Medicine, Mississippi State University, Starkville, United States.
Abstract:
The rapid integration of artificial intelligence (AI) and machine learning into predictive toxicology has transformed chemical hazard identification, toxicity endpoint forecasting, and risk assessment for pharmaceuticals, environmental pollutants, and consumer products. While these tools promise faster, more ethical alternatives to traditional testing, they introduce significant risks of algorithmic bias arising from imbalanced datasets, historical data limitations, under-represented chemical classes or populations, and model design choices. Such biases can lead to inaccurate predictions, disproportionate errors in vulnerable subgroups (e.g., demographic or geographic disparities in human health outcomes), and unreliable environmental safety evaluations. This review synthesises sources of bias in AI-powered toxicology models, including data selection, feature engineering, and black-box opacity. It examines detection methods (e.g., fairness metrics, disparity audits) and mitigation frameworks, encompassing data-centric approaches (diverse inclusion, debiasing techniques, synthetic data generation), algorithmic interventions (adversarial training, regularisation), and holistic strategies aligned with emerging principles such as trustworthiness, reproducibility, explainability, applicability, and transparency. Special emphasis is placed on explainable AI (XAI) methods, such as SHAP, LIME, attention mechanisms, and Grad-CAM visualisations, that enhance interpretability, reveal mechanistic insights, and facilitate bias identification in toxicity predictions. Applications to human health (e.g., reducing inequities in adverse drug reaction forecasting) and environmental safety (e.g., equitable chemical prioritisation and ecosystem risk modelling) are highlighted, alongside regulatory considerations for acceptance of bias-resilient, transparent models. Challenges persist, including data heterogeneity, validation gaps, and ethical oversight needs. Future directions call for standardised bias auditing protocols, interdisciplinary collaboration, and policy frameworks to ensure AI-driven toxicology delivers fair, reliable, and human-relevant outcomes for safer public and environmental health.
Related Concept Videos
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Toxicity Testing in Animals
Bias in Epidemiological Studies
Pharmaceutical Poisoning: Potential Scenarios
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...